South-East Asia Region


  • In South-East Asia, there are 39 million people living with hepatitis B. 
  • 10 million people in the region are living with hepatitis C.
  • There are an estimated 6.5 million symptomatic cases of hepatitis E and 400,000 cases of hepatitis A in the region each year.
  • The prevalence of chronic hepatitis B is above 8% in three countries: Democratic People's Republic of Korea, Myanmar and Timor-Leste
  • A recent study estimated hepatitis C infection rates in the general population at 2.7% in Thailand, 1.7% in Myanmar, 1.3% in Bangladesh, 1.3% in India and 0.8% in Indonesia.
  • 50% of people who inject drugs in the region have hepatitis C.


  • The hepatitis B vaccine is included in childhood immunisation programmes throughout the region. More than 24 million doses of the hepatitis B vaccine are administered in the region annually but only 7 countries have implemented the birth dose.

We must adopt coordinated national strategies based on the local epidemiological context. The battle against hepatitis cannot be won by ministries of health alone. […] Most importantly, the public must be armed with information to prevent viral hepatitis.

Dr Poonam Khetrapal Singh, WHO Regional Director for South-East Asia 

There is currently no content classified with this term.